Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2026-01-05 @ 6:30 PM
Study NCT ID:
NCT05485350
Status:
UNKNOWN
Last Update Posted:
2022-08-03
First Post:
2022-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Peking University Third Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ALTER-L056
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None